Patton Fund Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Patton Fund Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	SELL	$700.03 - $830.35 $192,508 - $228,346	-275 Reduced 6.33%	4,068 $2.92 Million
Q1 2023 Apr 06, 2023	BUY	$680.49 - $826.97 $685,933 - $833,585	1,008 Added 30.22%	4,343 $3.57 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $2.35 Million - $2.56 Million	3,335 New	3,335 $2.41 Million
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $1.37 Million - $1.74 Million	-2,864 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $41,401 - $50,023	-76 Reduced 2.59%	2,864 $1.6 Million
Q2 2020 Jul 08, 2020	BUY	$493.32 - $643.92 $1.45 Million - $1.89 Million	2,940 New	2,940 $1.83 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.